Tuesday, September 11, 2012 1:25:15 PM
ProShares announced today that on September 10, 2012, the United States District Court for the Southern District of New York dismissed, in its entirety, the class action lawsuit filed against the Company in 2009. The court rejected the plaintiffs’ claim that certain risks associated with holding leveraged and inverse ETFs for periods longer than one day were omitted from the disclosures set forth in the registration statements.
“We have maintained since the beginning of this case that the allegations were wholly without merit, and we are pleased that the claims have been dismissed in their entirety,” said Amy Doberman, ProShares’ General Counsel.
“ProShares has demonstrated a long-standing commitment to educating investors about our products and their risks and benefits, so it is gratifying that Judge Koeltl’s ruling rests on the strength and quality of our disclosures.”
In his order dismissing the case, Judge John G. Koeltl ruled that the registration statements accompanying ProShares leveraged and inverse ETFs stated “in plain English” their daily performance objectives and clearly disclosed the possibility that “the ETFs’ value could diverge significantly from the underlying index when the ETFs were held for longer than one day.”
Judge Koeltl’s ruling concluded that ProShares disclosures “addresse[d] the relevant risk directly” in a way that any “reasonably prudent investor would have understood.”
About ProShares
Offering the nation's largest lineup of alternative ETFs, ProShares enables investors to go beyond the limitations of conventional investing and meet today’s market challenges. Each ProShares ETF provides access to an alternative investment strategy delivered with the liquidity, transparency and cost effectiveness of an ETF. ProShares' lineup of 138 ETFs includes Global Fixed Income, Hedge Strategies, Geared (leveraged and inverse), and Inflation and Volatility ETFs.
ProShares’ geared (leveraged and inverse) ETFs seek returns that are 3x, 2x, -1x, -2x or -3x of the return of an index or other benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, ProShares' returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their ProShares holdings consistent with their strategies, as frequently as daily.
Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing. Obtain them from your financial advisor or broker/dealer representative or by visiting ProShares.com.
ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds' advisor or sponsor.
Recent SEIC News
- SEI Reports First-Quarter 2024 Financial Results • PR Newswire (US) • 04/24/2024 08:01:00 PM
- SEI to Announce First-Quarter 2024 Earnings on Wednesday, April 24, 2024 • PR Newswire (US) • 04/17/2024 01:00:00 PM
- SEI Enhances SMA and UMA Solutions Offered Through Managed Accounts Program • PR Newswire (US) • 04/02/2024 01:00:00 PM
- IXS Holdings Selects SEI for Cybersecurity and Network Operations • PR Newswire (US) • 03/27/2024 01:00:00 PM
- SEI Launches Advanced Multi-Custody Capability for U.S. Wealth Management Clients • PR Newswire (US) • 03/21/2024 01:00:00 PM
- Cullen Capital Management LLC Selects SEI's Advisors' Inner Circle Fund Trust to Launch First Active ETF • PR Newswire (US) • 03/07/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:45:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:24:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 04:54:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 09:04:09 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/22/2024 05:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 02:20:18 PM
- SEI and TIFIN Partner to Power the Future of Wealth Through Artificial Intelligence • PR Newswire (US) • 02/21/2024 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 06:40:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 04:57:46 PM
- Form 13F-HR - Quarterly report filed by institutional managers, Holdings • Edgar (US Regulatory) • 02/14/2024 01:34:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/12/2024 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 03:30:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/07/2024 09:52:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 03:33:35 PM
- Pictet Asset Management launches first suite of CITs and chooses SEI as strategic partner • PR Newswire (US) • 02/06/2024 02:00:00 PM
- SEI Attracts Large European and Global Asset Managers with CIT Lineup • PR Newswire (US) • 02/06/2024 02:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/05/2024 11:43:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 02:12:21 PM
- SEI Appoints Sean Denham as CFO • PR Newswire (US) • 02/05/2024 02:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM